All Stories

  1. The Japanese Postmarketing Adverse Event Relief System: A Confluence of Regulatory Science, the Legal System, and Clinical Pharmacology

    Article • Clinical Pharmacology & Therapeutics, December 2016, Wiley

    Toshiyoshi Tominaga